[{"indications": "Indications\u00a0\n(From Iron overload: British National Formulary)\nIron overload", "name": "DEFERASIROX", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.1 Anaemias and some other blood disorders", "9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias", "Iron overload", "DEFERASIROX"], "cautions": "Cautions\u00a0eye and ear examinations required before\r\ntreatment and annually during treatment; monitor body-weight, height, and sexual development in children annually; monitor serum-ferritin concentration monthly; elderly (increased risk of side-effects); risk of gastro-intestinal ulceration and haemorrhage; platelet count less than 50 \u00d7 109/litre; consider treatment interruption if unexplained cytopenia occurs; not recommended in conditions which may reduce life\r\nexpectancy (e.g. high-risk myelodysplastic syndromes); history of liver cirrhosis; test liver function before treatment, then every 2 weeks during the\r\nfirst month, and then monthly; measure\r\nbaseline serum creatinine and monitor renal function weekly during\r\nthe first month of treatment and monthly thereafter; test for proteinuria monthly; interactions: Appendix 1 (deferasirox)", "side-effects": "Side-effects\u00a0gastro-intestinal disturbances (including ulceration\r\nand fatal haemorrhage); headache; proteinuria; pruritus, rash; less commonly hepatitis, cholelithiasis, oedema, fatigue,\r\nanxiety, sleep disorder, dizziness, pyrexia, pharyngitis, glucosuria,\r\nrenal tubulopathy, disturbances of hearing and vision (including lens\r\nopacity and maculopathy), and skin pigmentation; hepatic failure,\r\nacute renal failure, blood disorders (including agranulocytosis, neutropenia,\r\npancytopenia, and thrombocytopenia), hypersensitivity reactions (including\r\nanaphylaxis and angioedema), alopecia also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129929.htm", "doses": ["adult and child over 2 years initially 10\u201330\u00a0mg/kg once daily\r\naccording to serum-ferritin concentration and amount of transfused\r\nblood (consult product literature); maintenance, adjust dose every\r\n3\u20136 months in steps of 5\u201310\u00a0mg/kg according to serum-ferritin concentration;\r\nusual max. 30\u00a0mg/kg daily, but may be increased to max. 40\u00a0mg/kg daily\r\nand reduced in steps of 5\u201310\u00a0mg/kg once control achieved"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless essential\u2014toxicity\r\nin animal studies"}]